Mayo Clinic has made important contributions to research on primary sclerosing cholangitis. Mayo Clinic researchers were among the first to originally describe the disease. Other research done at Mayo has helped to refine diagnostic tests, improve treatment and assess the results of liver transplants for people with primary sclerosing cholangitis. Mayo researchers also developed mathematical models to help physicians predict long-term survival for people with primary sclerosing cholangitis.

Mayo researchers are currently studying the use of the fluorescence in situ hybridization (FISH) test in the diagnosis of bile duct cancer in people with primary sclerosing cholangitis. Another study is looking at genetic predisposition to primary sclerosing cholangitis.

Publications

See a list of publications by Mayo Clinic doctors on primary sclerosing cholangitis on PubMed, a service of the National Library of Medicine.

Apr. 09, 2011